1. Home
  2. COGT vs ALM Comparison

COGT vs ALM Comparison

Compare COGT & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • ALM
  • Stock Information
  • Founded
  • COGT 2014
  • ALM N/A
  • Country
  • COGT United States
  • ALM Canada
  • Employees
  • COGT N/A
  • ALM N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • ALM Other Metals and Minerals
  • Sector
  • COGT Health Care
  • ALM Basic Materials
  • Exchange
  • COGT Nasdaq
  • ALM Nasdaq
  • Market Cap
  • COGT 1.1B
  • ALM 958.4M
  • IPO Year
  • COGT 2018
  • ALM N/A
  • Fundamental
  • Price
  • COGT $11.70
  • ALM $4.71
  • Analyst Decision
  • COGT Strong Buy
  • ALM Strong Buy
  • Analyst Count
  • COGT 9
  • ALM 2
  • Target Price
  • COGT $20.25
  • ALM $7.00
  • AVG Volume (30 Days)
  • COGT 1.8M
  • ALM 1.1M
  • Earning Date
  • COGT 08-05-2025
  • ALM 08-14-2025
  • Dividend Yield
  • COGT N/A
  • ALM N/A
  • EPS Growth
  • COGT N/A
  • ALM N/A
  • EPS
  • COGT N/A
  • ALM N/A
  • Revenue
  • COGT N/A
  • ALM $20,120,360.00
  • Revenue This Year
  • COGT N/A
  • ALM $167.51
  • Revenue Next Year
  • COGT N/A
  • ALM $107.39
  • P/E Ratio
  • COGT N/A
  • ALM N/A
  • Revenue Growth
  • COGT N/A
  • ALM 24.46
  • 52 Week Low
  • COGT $3.72
  • ALM $3.16
  • 52 Week High
  • COGT $12.97
  • ALM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • COGT 59.54
  • ALM N/A
  • Support Level
  • COGT $10.38
  • ALM N/A
  • Resistance Level
  • COGT $12.21
  • ALM N/A
  • Average True Range (ATR)
  • COGT 0.53
  • ALM 0.00
  • MACD
  • COGT -0.16
  • ALM 0.00
  • Stochastic Oscillator
  • COGT 64.13
  • ALM 0.00

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About ALM Almonty Industries Inc. Common Shares

Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.

Share on Social Networks: